Clinical Trial Update: Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness and safety of blinatumomab combined with donor lymphocyte infusion as maintenance therapy after allogeneic hematopoie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (Blincyto) (blinatumomab)
• Donor Lymphocyte Infusion

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Leukemia, Relapse | Phase 2 | Status: RECRUITING